Extremity medical devices made of our biomaterials are radiolucent enabling surgeons to visualise fusion, reduce stress shielding and cater for easier revision compared with metal.

The extremity device market was estimated in 2015 at $3.82 Billion and is forecasted to grow significantly.Orthopedic extremity devices, foot arthrodesis and arthroplasty volumes are expected to grow with deformity corrections performed in the foot driven by favorable demographic factors (obesity, diabetes) and becoming increasingly common due to rising aesthetic consciousness.

Pre-contoured anatomic and contourable plates for hand, foot and ankle, cannulated, compression screws and hammertoe and wedges for osteotomies offers some examples where our biomaterials can drive superior performance. Benefits include:

  • Bionert, biocompatible, no-resorbable biomaterial with a modulus of elasticity lower than metallic implant materials similar to cortical bone3
  • Radiolucency allowing  for a more accurate assessment of fusion4
  • Improved patient satisfaction5
  • Improved level of direct bone contact inas early as 4 weeks6
  • New bone formation in as early as 6 weeks7

PEEK-OPTIMATM is paving the way in extremity orthopedic technology with leading devices such as the CANNULINK™ Intraosseous fixation system by the Wright Medical Group N. V,8 TOEGRIP® implant for Inter-Phalangeal Fusion by SYNCHRO MEDICAL SARL,9 and HAT-TRICTM Proximal Inter-Phalangeal (PIP) Fusion by Smith&Nephew.10


1. Foot and Ankle Devices Market worth 5.41 Billion USD by 2020. Press release, Markets and Markets. Link: https://www.marketsandmarkets.com/PressReleases/foot-ankle-devices.asp

2. Supportive information available on request.

3. J. E. Isaacs, S. N. Yen, J. R Owen, F. P. Owings, J. S. Wayne (2008). Biomechanical comparison of the holding strength of a peek-optima circular plate versus a stainless steel oblique T-plate for radioscapholunate arthrodesis. J Hand Surg Am. 2008 Dec;33(10):1765-9 

4. P. C. Rheen, A. Shin (2013). The rate of successful four-corner arthrodesis with a locking, dorsal circular polyether-ether-ketone (PEEK-Optima) plate. J Hand Surg Eur Vol. 2013 Sep;38(7):767-73.

5. J. L. Harmer, A. Wilkinson, A. J. Maher (2017). A Midterm Review of Lesser Toe Arthrodesis With an Intramedullary Implant. Foot Ankle Spec. 2017 Apr 1:1938640017704943

6. Ovine bone defect study of PEEK-OPTIMATM HA Enhanced polymer, supportive information available on request.

7. Ovine cervical fusion study of PEEK-OPTIMATM Natural and HA Enhanced polymers, supportive information available on request.     

8. “CANNULINK” trademark is the property of Wright Medical Group N.V. or its affiliates.

9. “TEOGRIP” registered trademark is the property of SYNCHRO MEDICAL SARL

10. “HAT-TRICK” trademark is the property of Smith&Nephew

Receive the latest clinical evidence and data for PEEK-OPTIMA based applications

By completing this form you are signing up for marketing updates. You will receive targeted messages such as newsletters, tradeshow, webinar and event announcements from Invibio, a member of the Victrex Group. You can unsubscribe at any time. Visit our Privacy Policy to learn more.
The materials on this site are intended for Health Care Professionals and industry users only. If you are a patient, click here, otherwise, click continue.